Arkolith/Insider Trading/CGON/Form 4

Post Leonard E

DirectorCG Oncology, Inc. (CGON) · full profile →Form 4 · filed Jun 5, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$55K
Net Open-Market Flow
-$55K
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 4, 2026Option exercise(M)1K$0.60$6001K
Jun 4, 2026Sell(S)1K$54.50$55K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 4, 2026Option exercise(M)1K—$0116K
Jun 4, 2026Grant(A)9K—$09K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-259705) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML